Unlock Insights: Voyageur Pharmaceuticals' Corporate Video Presentation
Voyageur Pharmaceuticals Ltd.
Pharmaceutical Manufacturing
Calgary, Alberta 535 followers
From the Earth to the Bottle
About us
Voyageur Pharmaceuticals Ltd. | VM.TSX Voyageur Pharmaceuticals Ltd. is an entrepreneurial driven company headquartered in Canada, specializing in the development and manufacturing of natural based contrast agents for diagnostic imaging technologies. Our trading symbol is VM.TSX on the Toronto Venture Exchange, testament to our robust corporate positioning and transparent operations. Our primary offerings span across the realms of CT, Fluoroscopy, MRI, and Ultrasound imaging. We proudly source Barium and Iodine directly from the earth, rigorously purifying these minerals into Active Pharmaceutical Ingredients (APIs), before culminating the process in the creation of finished drug products. This complete, end-to-end production chain aligns seamlessly with our motto - “From the Earth to the Bottle”. On the frontier of innovation, Voyageur Pharmaceuticals is also actively engaged in Fullerene drug development. This remarkable technology harnesses the potential of carbon capture through the Eden system, turning captured carbon into Fullerenes, thus laying the groundwork for a new, revolutionary drug development program. Our operations are rooted in a scientific and drug-oriented focus, keeping patient well-being and improved diagnostic accuracy at the heart of our mission. Committed to excellence and innovation, Voyageur Pharmaceuticals Ltd. is not just about mining resources; it’s about mining the future of healthcare. We invite you to connect with us, be part of our story, and explore the boundless opportunities that lie at the intersection of nature, science, and technology.
- Website
-
https://voyageurpharmaceuticals.ca/
External link for Voyageur Pharmaceuticals Ltd.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Calgary, Alberta
- Type
- Public Company
- Founded
- 2013
- Specialties
- API Processor, Highest Grade Barium, Pharmaceutical Manufacture , Diagnostic Imaging , Barium Contrast Agent, Iodine Contrast Agent , and Fullerene Contrast Agent
Locations
-
Primary
Calgary, Alberta, CA
Employees at Voyageur Pharmaceuticals Ltd.
Updates
-
Voyageur Pharmaceuticals Ltd. reposted this
Voyageur Pharmaceuticals Ltd. (TSX-V:VM, OTC:VYYRF) announced it has signed a letter of intent with a major multinational pharmaceutical company to enhance efficiencies in the production of contrast media products. The collaboration expands Voyageur’s project portfolio and diversifies its product mix. More at #Proactive #ProactiveInvestors http://ow.ly/oUx0105SaKX
-
Voyageur Pharmaceuticals Ltd. reposted this
News Release: Voyageur Pharmaceuticals Ltd. (TSXV: VM) Announces Proposed Private Placement https://bit.ly/40bfdnE #barium #radiology #medicalimaging
Voyageur Announces Proposed Private Placement
https://investornews.com
-
Voyageur Pharmaceuticals Ltd. reposted this
This article delves into the growth and advancements of Voyageur Pharmaceuticals, specializing in imaging contrast agents and pharmaceutical Innovations, highlighting our recent achievements, executive team developments, international sales agreements, and future product developments. Investors seeking opportunities in the pharmaceutical sector may find valuable insights and potential in Voyageur Pharmaceuticals Ltd.'s strategic trajectory and innovative initiatives. https://lnkd.in/gzWdGdze
-
Join Us for a Panel Discussion at Life Science Week, Hosted by Our R&D Partners, Applied Pharmaceutical Innovation – September 23-27
The Latest on Life Sciences Innovation in Calgary & Region! 🧬🌎 Explore the vibrant and thriving life sciences innovation ecosystem in the Calgary region! Crystal Phillips from Thin Air Labs will be moderating an engaging panel session showcasing a range of local innovative life sciences companies. Get ready for a dynamic, rapid-fire Q&A session that will keep the conversation lively and powerful insights flowing! 📅 Date: Wednesday, September 25 🕛 Time: 11:00 AM - 11:45 AM 📍 Location: Studio Bell, Calgary, Alberta Panelists Include: Brent Willis B.sc.Eng, CEO, Voyageur Pharmaceuticals Ltd. Peter Calverley, Chairperson, Orpyx® Medical Technologies Dr. Faisal Masood Khan, CEO and Co-Founder, OncoHelix Jumai Abioye, PhD, Founder & CEO, PanAccess Innovations Inc. Josh Abbott, CEO, Tangent Design Engineering John Wong, CEO & Co-Founder, Fluid Biomed Inc. Moderator: Crystal Phillips - Vice President, Thin Air Labs Don’t miss out—join us for an exciting deep dive into the cutting-edge life sciences innovations shaping Calgary and the region! 👉 https://lu.ma/9w6m3mti #LifeSciencesWeek #Innovation #Entrepreneurs #Startups #LifeSciences #Calgary
-
Voyageur Pharmaceuticals Ltd. reposted this
Voyageur Pharmaceuticals Ltd. CEO Brent Willis joined Steve Darling from Proactive to announce the successful completion of formulation work for the company’s latest product line, which includes five Health Canada-licensed products. These advanced formulations are set to raise industry standards, offering enhanced value to healthcare providers and stakeholders. Willis also revealed the launch of two new product brands, Vision and Smooth barium contrast agents, aimed at improving versatility and performance in medical diagnostics. Watch at #Proactive #ProactiveInvestors http://ow.ly/F0rY105J5sj
Voyageur Pharmaceuticals announces new line of Barium Contrast Formulations setting new standard
proactiveinvestors.com